In certain embodiments, any controlled-release otic formulation described herein increases the exposure of an active agent and increases the Area Under the Curve (AUC) in otic fluids (e.g., endolymph and/or perilymph) by about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 100%, or higher than 100%, compared to an otic formulation that is not a controlled-release otic formulation
EBJ 16, 121129
Careful not to go too low (seek instruction)
B12 Injection Treatment Protocols and Schedules Fixing Vitamin B12 deficiency needs a clear plan
For researchers who switch from tirzepatide to retatrutide or are comparing all three compounds , the storage protocols transfer almost directly
If your doctor tries to get you off the shots in favor of oral B12 supplements (tablets, spray, etc), do not accept that as treatment